argus

SYMBIOTEC PHARMALAB LIMITED

NSE: SYMBIOTECINE899I010287,159 Cr

Timeline

Time (IST)TypeMEventSrc
01 Sept, 04:36 pmprocedural0Procedural intimation of a disclosure under Reg 30(5) with no economic substance or numbers provided.nse
01 Sept, 04:29 pmprocedural0Symbiotec Pharmalab Limited has informed the Exchange regarding an intimation under Regulation 8(2) of the SEBI (PIT) Regulations 2015, which is a pure procedural filing with zero investor information.nse
01 Sept, 08:17 amprocedural0Equity shares of Symbiotec Pharmalab Ltd listed and admitted to trading on BSE effective September 01, 2026 in the 'B' Group Securities list.bse